JC: Keep on blocking in the free world. Remi vs. NMB for RSI. St Emlyn’s
Dan Horner reviews the JAMA paper on remifentanyl vs. neuromuscular blocking agents (NMBs) for RSI. #FOAMed @stemlyns
Dan Horner reviews the JAMA paper on remifentanyl vs. neuromuscular blocking agents (NMBs) for RSI. #FOAMed @stemlyns
Is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Research in cardiac arrest management has improved a lot in recent years. We are now seeing large randomised controlled trials looking at specific therapies in the management of these critically …
Summer hols and quiet times for many of us at present, so apologies for lack of posts. There is always stuff going on in the background however, and several of …
This week we have a nice paper that highlights some of the ongoing thoughts and controversies about the use of calcium in major haemorrhage protocols. Hopefully you’ve already read Iain’s …
More on Calcium and blood products in trauma. St Emlyn’s Read More »
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last …
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More »
As several of you may know already, I’ve been spending a lot more time in the pre-hospital environment in the last few years. Despite many years working in busy emergency …
The EXIT study extrication consensus statements. St Emlyn’s Read More »
As someone who works across both PEM and adult EM it’s interesting to reflect on how the workload varies. These days my adult work is heavily skewed to complex majors …